focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,370.00
Bid: 4,335.00
Ask: 4,340.00
Change: 50.00 (1.16%)
Spread: 5.00 (0.115%)
Open: 4,310.00
High: 4,380.00
Low: 4,310.00
Prev. Close: 4,370.00
CWK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Third quarter trading statement

2 Feb 2023 07:00

RNS Number : 6545O
Cranswick PLC
02 February 2023
 

2 February 2023

 

Cranswick plc

("Cranswick" or "the Company" or "the Group")

 

 

Third quarter trading statement

 

Cranswick, a leading UK food producer, today provides its scheduled update on trading for the 13 weeks to 24 December 2022.

 

Current trading

Revenue growth accelerated in the third quarter, building on the momentum generated in the first half of the year. All four product categories were strongly ahead of the corresponding period in our core UK market, reflecting solid underlying volume growth together with further cost inflation recovery. Trading in December was particularly robust, underpinned by strong demand for our Fresh Pork, Convenience and Gourmet festive range of products. Our customers and consumers continue to recognise and appreciate the quality, value and versatility of pork.

 

Poultry revenue growth reflected a positive contribution from the new Hull breaded poultry facility which offset lower sales from the Hull cooked poultry facility. There was a very limited impact on Fresh Poultry revenue following Avian Influenza outbreaks at five farms across our poultry farm estate early in the period; we have received full financial compensation for all lost birds. In recent weeks the incidence of confirmed cases in the UK has reduced, but we continue to enforce strict biosecurity protocols across all our farms.

 

Far East export sales were well ahead of the same period last year, with slightly lower volumes comfortably offset by significantly stronger pricing.

 

Cranswick Pet Products made a modest contribution to Group revenue in the third quarter. During the period we made further progress in reshaping the business for the future to create a more efficient manufacturing operation with a strong complementary customer base.

 

Investment

Our broad-based investment plans remain firmly on track with several substantial projects in progress which will enhance the capability of and add capacity to several of our flagship production facilities as well as driving through further operating efficiencies. We have also committed to a number of capital projects which support our 'Second Nature' sustainability programme.

 

During the period we invested further in our pig farming operations and, in so doing, we have lifted our self-sufficiency to over 40% of our total requirement for British pigs.

 

Defined benefit pension scheme

A subsidiary of the Group operates a legacy defined benefit pension scheme for certain employees, towards which the Group was contributing cash of £1.8 million each year. In December 2022, a buy-in contract was purchased for £3.7 million, which secures members benefits in full, sees all the scheme's financial and demographic risks hedged and requires no further future cash contributions by Cranswick. 

 

'Second Nature' Sustainability

In December 2022 we received confirmation of our latest Carbon Disclosure Project (CDP) scores: grade A- for Climate and grade B- for Soya within Forests were both a grade improvement on the previous year. Our new, improved grades reflect our continued focus on and commitment to delivering our industry leading 'Second Nature' strategy.

 

Financial position

As expected, net debt increased during the period, reflecting the usual seasonal uplift in working capital, further investment in biological assets and our ongoing capital investment programme. The Group remains in a robust financial position with committed, unsecured facilities of £250 million providing comfortable headroom.

 

Outlook

The outlook for the current financial year remains in line with the Board's expectations.

 

The Board is confident that the continued focus on the strengths of the Company, which include its long-standing customer base, breadth and quality of products, robust financial position and industry leading asset infrastructure, will support the further successful development of Cranswick during the current year and over the longer term.

 

Preliminary results

The Company's next scheduled comment on trading will be the preliminary results announcement for the 52 weeks ending 25 March 2023, on Tuesday 23 May 2023.

 

Adam Couch, CEO of Cranswick, commented:

"We have delivered another strong quarter of growth, building on the momentum generated in the first half of the year. Our core UK market remains extremely resilient as our customers and the UK consumer continue to recognise and appreciate the quality, value and versatility of our pork and poultry product ranges.

 

"The broad-based inflationary pressure we are experiencing across our cost base continues to be well controlled and mitigated.

 

"Our relentless focus on innovation together with the passion and dedication of our people are the key enablers of our continued successful progress and development. I would like to thank all of our colleagues for their ongoing commitment and support."

 

Enquiries:

 

Cranswick plc

01482 275 000

Mark Bottomley, Chief Financial Officer

Powerscourt

020 7250 1446

Nick Dibden / Elizabeth Kittle

cranswick@powerscourt-group.com

 

Notes:

1. Cranswick is a leading and innovative supplier of premium, fresh and added-value food products. The business employs over 13,700 people and operates from 20 well-invested, highly efficient facilities in the UK.

 

Cranswick was formed in the early 1970s by farmers in East Yorkshire to produce animal feed and has since evolved into a business which produces a range of high quality, predominantly fresh food, including fresh pork, poultry, convenience, gourmet products and pet food. The business develops innovative, great tasting food products to the highest standards of food safety and traceability. The Group supplies the major grocery multiples as well as the growing premium and discounter retail channels. Cranswick also has a strong presence in the 'food-to-go' sector and a substantial export business. Results for the 52 weeks to 26 March 2022 showed revenue of £2,008.5m and profit before tax of £129.9m. For more information go to: www.cranswick.plc.uk

 

2. Cranswick is committed to ensuring that its business activities are sustainable from farm-to-fork. Its ambitious sustainability strategy 'Second Nature' has been developed to deliver the Group's vision to become the world's most sustainable meat business. Cranswick has committed to be a Net Zero business across its operations by 2040. Find out more at: www.thisissecondnature.co.uk

 

3. This information is based on information sourced from unaudited management accounts.

 

4. This announcement contains certain forward-looking statements with respect to the financial conditions, results of operations and businesses of Cranswick. These statements involve risk and uncertainty because they relate to events and depend upon circumstances that will occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLTFSILIIV
Date   Source Headline
15th May 20245:22 pmRNSDirector/PDMR Shareholding
2nd May 20249:26 amRNSTotal Voting Rights
2nd Apr 20241:55 pmRNSBlock listing Interim Review
2nd Apr 20241:54 pmRNSBlock listing Interim Review
2nd Apr 20241:50 pmRNSTotal Voting Rights
27th Mar 20249:58 amRNSDirector/PDMR Shareholding
21st Mar 20241:57 pmRNSDirector/PDMR Shareholding
21st Mar 20241:55 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSDirectorate Change
15th Mar 20243:58 pmRNSDirector/PDMR Shareholding
4th Mar 20249:58 amRNSTotal Voting Rights
14th Feb 202410:11 amRNSDirector/PDMR Shareholding
14th Feb 202410:11 amRNSDirector/PDMR Shareholding
2nd Feb 202411:00 amRNSTotal Voting Rights
18th Jan 20247:00 amRNSThird quarter trading statement
3rd Jan 20247:00 amRNSDirector/PDMR Shareholding
2nd Jan 20243:05 pmRNSTotal Voting Rights
5th Dec 20232:25 pmRNSDirector/PDMR Shareholding
1st Dec 20231:34 pmRNSDirector/PDMR Shareholding
29th Nov 20239:18 amRNSIssue of Equity
21st Nov 20237:00 amRNSInterim Results
1st Nov 20233:21 pmRNSTotal Voting Rights
30th Oct 20239:09 amRNSHolding(s) in Company
5th Oct 202312:18 pmRNSBLOCK LISTING SIX MONTHLY RETURN
5th Oct 202312:15 pmRNSBLOCK LISTING SIX MONTHLY RETURN
5th Oct 202312:10 pmRNSTotal Voting Rights
12th Sep 20232:06 pmRNSDirector/PDMR Shareholding
12th Sep 20232:05 pmRNSDirector/PDMR Shareholding
12th Sep 20232:03 pmRNSDirector/PDMR Shareholding
12th Sep 20232:02 pmRNSDirector/PDMR Shareholding
4th Sep 202310:30 amRNSTotal Voting Rights
29th Aug 20231:58 pmRNSDirectorate Change
29th Aug 202310:56 amRNSDirector/PDMR Shareholding
1st Aug 202312:16 pmRNSTotal Voting Rights
24th Jul 20235:56 pmRNSResult of AGM
24th Jul 20237:00 amRNSFirst quarter trading statement
3rd Jul 20232:04 pmRNSTotal Voting Rights
3rd Jul 20232:03 pmRNSDirector/PDMR Shareholding
3rd Jul 20231:57 pmRNSDirector/PDMR Shareholding
3rd Jul 20231:56 pmRNSDirector/PDMR Shareholding
14th Jun 20238:21 amRNSHolding(s) in Company
5th Jun 20235:18 pmRNSTotal Voting Rights
1st Jun 20234:08 pmRNSDirector/PDMR Shareholding
23rd May 20237:01 amRNSDirector Appointment and Board Changes
23rd May 20237:00 amRNSPRELIMINARY RESULTS
2nd May 202312:56 pmRNSTotal Voting Rights
19th Apr 20232:44 pmRNSBlock listing Interim Review
19th Apr 20232:43 pmRNSBlock listing Interim Review
5th Apr 20239:00 amRNSAdditional Listing
4th Apr 20239:30 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.